WO2003059264A3 - Methods for the induction of professional and cytokine-producing regulatory cells - Google Patents
Methods for the induction of professional and cytokine-producing regulatory cells Download PDFInfo
- Publication number
- WO2003059264A3 WO2003059264A3 PCT/US2002/041288 US0241288W WO03059264A3 WO 2003059264 A3 WO2003059264 A3 WO 2003059264A3 US 0241288 W US0241288 W US 0241288W WO 03059264 A3 WO03059264 A3 WO 03059264A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- cytokine
- induction
- professional
- regulatory cells
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02799306A EP1463799A4 (en) | 2001-12-21 | 2002-12-20 | PROCESS FOR INDUCTION OF LEARNED AND CYTOKINE-PRODUCING REGULATORY CELLS |
AU2002364230A AU2002364230B2 (en) | 2001-12-21 | 2002-12-20 | Methods for the induction of professional and cytokine-producing regulatory cells |
JP2003559429A JP2005514054A (en) | 2001-12-21 | 2002-12-20 | Methods for the induction of professional and cytokine-producing regulatory T cells |
CA002469800A CA2469800A1 (en) | 2001-12-21 | 2002-12-20 | Methods for the induction of professional and cytokine-producing regulatory cells |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34265501P | 2001-12-21 | 2001-12-21 | |
US60/342,655 | 2001-12-21 | ||
US37410202P | 2002-04-19 | 2002-04-19 | |
US60/374,102 | 2002-04-19 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2003059264A2 WO2003059264A2 (en) | 2003-07-24 |
WO2003059264A3 true WO2003059264A3 (en) | 2004-02-12 |
WO2003059264A9 WO2003059264A9 (en) | 2004-11-11 |
Family
ID=26993124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/041288 WO2003059264A2 (en) | 2001-12-21 | 2002-12-20 | Methods for the induction of professional and cytokine-producing regulatory cells |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1463799A4 (en) |
JP (1) | JP2005514054A (en) |
AU (1) | AU2002364230B2 (en) |
CA (1) | CA2469800A1 (en) |
WO (1) | WO2003059264A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2558879A1 (en) * | 2004-02-12 | 2005-08-25 | Immuno Frontier, Inc. | Regulatory cell controlling immunological activity of t cell |
US8053235B2 (en) | 2004-10-29 | 2011-11-08 | Benaroya Research Institute At Virginia Mason | Methods of generating antigen-specific CD4+CD25+regulatory T cells, compositions and methods of use |
AU2006285446B2 (en) * | 2005-08-31 | 2013-08-22 | Tla Targeted Immunotherapies Ab | Treatment of inflammatory bowel disease |
ITRM20070437A1 (en) * | 2007-08-10 | 2009-02-11 | Istituto Naz Per Le Malattie I | METHOD FOR THE GENERATION AND EXPANSION OF CELLS T RANGE / DELTA REGULATORY CELLS SOON OBTAINED AND THEIR APPLICATIONS |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0497275A2 (en) * | 1991-01-31 | 1992-08-05 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Generation of CD4+ helper T cells with interleukin 2 and interleukin 4 from L-phenylalanine methyl ester treated human peripheral blood cells |
WO2000042856A1 (en) * | 1999-01-22 | 2000-07-27 | The Schepens Eye Research Institute, Inc. | Activation of regulatory t cells by alpha-melanocyte stimulating hormone |
US6228359B1 (en) * | 1997-11-05 | 2001-05-08 | University Of Southern California | Use of cytokines and mitogens to inhibit pathological immune responses |
US20020034500A1 (en) * | 2000-08-15 | 2002-03-21 | Levings Megan K. | Regulatory T cells; methods |
EP1241249A1 (en) * | 2001-03-12 | 2002-09-18 | Gerold Schuler | CD4+CD25+regulatory T cells from human blood |
FR2824567A1 (en) * | 2001-05-11 | 2002-11-15 | Inst Nat Sante Rech Med | PROCESS FOR OBTAINING TR1 LYMPHOCYTES SPECIFIC ANTIGEN REGULATORS |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001077299A2 (en) * | 2000-04-11 | 2001-10-18 | University Of Southern California | A METHOD TO PREVENT GRAFT REJECTION USING TGF-β TO INDUCE T SUPPRESSOR CELLS |
-
2002
- 2002-12-20 WO PCT/US2002/041288 patent/WO2003059264A2/en active Application Filing
- 2002-12-20 EP EP02799306A patent/EP1463799A4/en not_active Withdrawn
- 2002-12-20 CA CA002469800A patent/CA2469800A1/en not_active Abandoned
- 2002-12-20 JP JP2003559429A patent/JP2005514054A/en active Pending
- 2002-12-20 AU AU2002364230A patent/AU2002364230B2/en not_active Ceased
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0497275A2 (en) * | 1991-01-31 | 1992-08-05 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Generation of CD4+ helper T cells with interleukin 2 and interleukin 4 from L-phenylalanine methyl ester treated human peripheral blood cells |
US6228359B1 (en) * | 1997-11-05 | 2001-05-08 | University Of Southern California | Use of cytokines and mitogens to inhibit pathological immune responses |
WO2000042856A1 (en) * | 1999-01-22 | 2000-07-27 | The Schepens Eye Research Institute, Inc. | Activation of regulatory t cells by alpha-melanocyte stimulating hormone |
US20020034500A1 (en) * | 2000-08-15 | 2002-03-21 | Levings Megan K. | Regulatory T cells; methods |
EP1241249A1 (en) * | 2001-03-12 | 2002-09-18 | Gerold Schuler | CD4+CD25+regulatory T cells from human blood |
FR2824567A1 (en) * | 2001-05-11 | 2002-11-15 | Inst Nat Sante Rech Med | PROCESS FOR OBTAINING TR1 LYMPHOCYTES SPECIFIC ANTIGEN REGULATORS |
Non-Patent Citations (2)
Title |
---|
LEVINGS M. ET AL.: "Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function", JOURNAL OF EXPERIMENTAL MEDICINE, vol. 193, no. 11, 2001, pages 1295 - 1301, XP002210571 * |
YAMAGIWA ET AL.: "The role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood", JOURNAL OF IMMUNOLOGY, vol. 166, no. 12, 2001, pages 7282 - 7289, XP002969113 * |
Also Published As
Publication number | Publication date |
---|---|
EP1463799A4 (en) | 2006-01-18 |
EP1463799A2 (en) | 2004-10-06 |
AU2002364230A1 (en) | 2003-07-30 |
CA2469800A1 (en) | 2003-07-24 |
WO2003059264A2 (en) | 2003-07-24 |
AU2002364230B2 (en) | 2008-05-01 |
WO2003059264A9 (en) | 2004-11-11 |
JP2005514054A (en) | 2005-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2561799A (en) | Radiotelephone adapted to the identity of its user | |
AU2003248331A1 (en) | Hybrid membrane, method for producing the same and use of said membrane | |
AU144678S (en) | Bottle | |
AU153659S (en) | Container | |
AU2002224927A1 (en) | Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds | |
ID23374A (en) | HALOGENOPIRIMIDIN | |
WO2003059356A3 (en) | Novel anti-infectives | |
MY133969A (en) | Indoloquinazolinones | |
AU2002321292A1 (en) | Hybrid membrane, method for the production thereof and use of said membrane | |
AU2003219100A1 (en) | Pyrazolopyridazine derivatives, process for preparation and use for the inhibition of gsk-3 | |
WO2000063247A3 (en) | Osteopontin-derived chemotactic and inhibitory agents and uses therefor | |
EP1261623A4 (en) | New retinol derivatives, the method of preparations and the uses thereof | |
WO2003059264A3 (en) | Methods for the induction of professional and cytokine-producing regulatory cells | |
AU9569998A (en) | Photo-spectrometers, methods of use and manufacture | |
AU2001287218A1 (en) | The use of melatonin for induction of general anesthesia | |
AU2002309646A1 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
AU2002320079A1 (en) | Vaccines, immunotherapeutics and methods of using the same | |
EP1517879A4 (en) | Aminoalkylphenols, methods of using and making the same | |
MXPA04004526A (en) | N-methyl-homocystines, use thereof and method for the production thereof. | |
DE60018253D1 (en) | The use of 5-carboxanilido-2,4-bis-trifluoromethylthiazole against rice tanning | |
AU2001233588A1 (en) | New toralactone and its derivation and the use of decreasing blood-fat and losing weight | |
AU2003246485A1 (en) | Interactions of the epstein-barr virus protein ebna1, and uses thereof | |
WO2001098512A3 (en) | Control of metabolism with compositions of the human 2-oxoglutarate carrier | |
AU7478098A (en) | Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies | |
AU2002303232A1 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002364230 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2469800 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003559429 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002799306 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002799306 Country of ref document: EP |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/19-19/19, DRAWINGS, REPLACED BY NEW PAGES 1/16-16/16; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |